This is the link to the Global sight of judicious use of antibiotics. I am seeing more publications in medical journals, "again", and it is, imo, one of the "extras" (HUGE) of the defensin-memetic approach. It is mind boggling to predict where this will lead. Just the B platform! I know of not one MD that have worked with over the last 35 years, that if they were to look at what we have, let me just say it would be like finding the Holy Grail for fighting many infectious bacteria. Have watched on front lines as these "superbugs" came to fruition and our top guns are no longer effective. BP is damn sure aware of what we have, imo, and it is just a matter of "the deal" being appropriate to its true and estimated value. Estimated value is low on any predictions I have seen, just been my opinion for awhile. The infectious control community well knows that the data gathered is still an estimation and regareded as on the low side of incidents. As a practitioner, I can gurantee that B alone will set the medical field on fire. Imagine meeting production quotas will be a nightmare. Of the best kind!!!
(4)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links